Search Results | Scholarly Articles, Journals, and E-Books

Results: 9

Masthead.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. fmi, doi. 10.1002/ddr.430190401
Publication type:
Article
Antagonizing bradykinin (BK) obliterates the cardioprotective effects of bradykinin and angiotensin-converting enzyme (ACE) Inhibitors in ischemic hearts.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 393, doi. 10.1002/ddr.430190405
By:
- Linz, Wolfgang;
- Martorana, Piero A.;
- Grösch, Horst;
- Bei-Yin, Qi;
- Schölkens, Bernward A.
Publication type:
Article
Monosialogangliosides (GM1 and AGF2) reduce acute ethanol intoxication: Sleep time mortality, and cerebral cortical Na+, K+-ATPase.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 443, doi. 10.1002/ddr.430190409
By:
- Hungund, Basalingappa L.;
- Reddy, Mary V.;
- Bharucha, Vandana A.;
- Mahadik, Sahebarao P.
Publication type:
Article
Loreclezole (R 72 063): An anticonvulsant chemically unrelated to prototype antiepileptic drugs.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 375, doi. 10.1002/ddr.430190404
By:
- Wauquier, Albert;
- Fransen, Joannes;
- Melis, William;
- Ashton, David;
- Gillardin, Jean-Marie;
- Lewi, Paul J.;
- Van Clemen, Gust;
- Vaught, Jeffrey;
- Janssen, Paul A. J.
Publication type:
Article
Inhibition of guinea pig aortic sarcolemmal Ca2+-Mg2+ ATPase and cAMP phosphodiesterase activity by milrinone.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 435, doi. 10.1002/ddr.430190408
By:
- O'Connor, Bernard;
- Silver, Paul J.
Publication type:
Article
Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the rat.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 353, doi. 10.1002/ddr.430190403
By:
- Meert, Theo F.;
- De Haes, Patrick L. A. J.;
- Vermote, Patrick C. M.;
- Janssen, Paul A. J.
Publication type:
Article
Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 425, doi. 10.1002/ddr.430190407
By:
- Becker, Robert E.;
- Colliver, Jerry;
- Elble, Rodger;
- Feldman, Eleanor;
- Giacobini, Ezio;
- Kumar, Vinod;
- Markwell, Stephen;
- Morieatry, Pamela;
- Parks, Randolph;
- Schillcutt, Samuel D.;
- Unni, Latha;
- Vicari, Sandra;
- Womack, Cindy;
- Zec, Ronald F.
Publication type:
Article
Neuropeptide Y: An overview.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 329, doi. 10.1002/ddr.430190402
By:
- Lehmann, John
Publication type:
Article
On the mechanism of increased potassium conductance by the potassium channel opener BRL 34915 in Isolated ventricular myocytes.
Published in:
Drug Development Research, 1990, v. 19, n. 4, p. 409, doi. 10.1002/ddr.430190406
By:
- Liu, Bo;
- McCullough, John R.;
- Vassalle, Mario
Publication type:
Article

Masthead.

Antagonizing bradykinin (BK) obliterates the cardioprotective effects of bradykinin and angiotensin-converting enzyme (ACE) Inhibitors in ischemic hearts.

Monosialogangliosides (GM1 and AGF2) reduce acute ethanol intoxication: Sleep time mortality, and cerebral cortical Na<sup>+</sup>, K<sup>+</sup>-ATPase.

Loreclezole (R 72 063): An anticonvulsant chemically unrelated to prototype antiepileptic drugs.

Inhibition of guinea pig aortic sarcolemmal Ca<sup>2+</sup>-Mg<sup>2+</sup> ATPase and cAMP phosphodiesterase activity by milrinone.

Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the rat.

Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial.

Neuropeptide Y: An overview.

On the mechanism of increased potassium conductance by the potassium channel opener BRL 34915 in Isolated ventricular myocytes.